Scarica l'app Stockscreener
21.48
3.87%
0.80
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$20.68
Aprire:
$20.59
Volume 24 ore:
396.60K
Relative Volume:
2.25
Capitalizzazione di mercato:
$870.02M
Reddito:
$982.01M
Utile/perdita netta:
$14.80M
Rapporto P/E:
58.05
EPS:
0.37
Flusso di cassa netto:
$37.02M
1 W Prestazione:
+3.62%
1M Prestazione:
-7.89%
6M Prestazione:
+25.32%
1 anno Prestazione:
+90.93%
Intervallo 1D:
$20.25
$21.82
Intervallo di 1 settimana:
$20.25
$21.82
Portata 52W:
$10.04
$25.98
Phibro Animal Health Corp Stock (PAHC) Company Profile
Nome
Phibro Animal Health Corp
Settore
Telefono
201-329-7300
Indirizzo
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Confronta PAHC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PAHC
Phibro Animal Health Corp
|
21.48 | 870.02M | 982.01M | 14.80M | 37.02M | 0.37 |
|
ZTS
Zoetis Inc
|
165.02 | 74.45B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.49 | 42.91B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.24 | 41.98B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.49 | 24.35B | 16.77B | -959.00M | 1.37B | -0.85 |
|
VTRS
Viatris Inc
|
11.96 | 14.28B | 15.05B | -883.30M | 1.89B | -0.74 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-09-10 | Iniziato | JP Morgan | Neutral |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Underperform |
| 2022-12-21 | Iniziato | ROTH Capital | Buy |
| 2022-07-25 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-01-10 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2021-11-18 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-08-05 | Ripresa | Credit Suisse | Neutral |
| 2021-07-07 | Downgrade | Barclays | Equal Weight → Underweight |
| 2020-08-06 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2020-02-06 | Downgrade | Gabelli & Co | Buy → Hold |
| 2020-01-28 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2019-09-05 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2019-08-29 | Reiterato | BofA/Merrill | Underperform |
| 2019-06-11 | Iniziato | Barclays | Underweight |
| 2019-05-23 | Iniziato | Guggenheim | Neutral |
| 2019-05-09 | Aggiornamento | Gabelli & Co | Hold → Buy |
| 2017-08-23 | Ripresa | BofA/Merrill | Underperform |
| 2017-06-02 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2016-12-15 | Iniziato | Piper Jaffray | Overweight |
| 2016-11-11 | Downgrade | Macquarie | Neutral → Underperform |
| 2016-11-10 | Downgrade | Gabelli & Co | Buy → Hold |
| 2016-04-11 | Reiterato | Guggenheim | Buy |
| 2016-02-04 | Iniziato | Credit Suisse | Outperform |
| 2016-01-15 | Downgrade | Barclays | Overweight → Underweight |
| 2015-09-30 | Iniziato | Gabelli & Co | Buy |
| 2015-04-24 | Reiterato | Barclays | Overweight |
| 2015-04-21 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2014-05-06 | Iniziato | Barclays | Overweight |
Mostra tutto
Phibro Animal Health Corp Borsa (PAHC) Ultime notizie
Expanding Global Network, Vaccine Sales Support PAHC Stock - Yahoo Finance
Zacks Research Has Positive Forecast for PAHC Q2 Earnings - MarketBeat
Phibro Animal Health (NASDAQ:PAHC) Sees Strong Trading VolumeStill a Buy? - MarketBeat
3 Reasons Growth Investors Will Love Phibro (PAHC) - Yahoo Finance Australia
Growth Trends in the Porcine Vaccines Market, Forecast to 2028: Increasing Government Initiatives for Funding Animal Husbandry - GlobeNewswire Inc.
Is Phibro Animal Health (PAHC) a Great Value Stock Right Now? - Yahoo Finance
Phibro Animal Health Co. (NASDAQ:PAHC) Shares Sold by Principal Financial Group Inc. - Defense World
Phibro Animal Health (NASDAQ:PAHC) Raised to Strong-Buy at StockNews.com - Defense World
Phibro Animal Health Gains 83% in a Year: What's Driving the Stock? - MSN
Reasons to Retain Phibro Stock in Your Portfolio Now - MSN
Geode Capital Management LLC Has $11.43 Million Holdings in Phibro Animal Health Co. (NASDAQ:PAHC) - MarketBeat
Sanctuary Advisors LLC Has $279,000 Stock Holdings in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Should Value Investors Buy Phibro Animal Health (PAHC) Stock? - MSN
Phibro Animal Health (NASDAQ:PAHC) Downgraded by StockNews.com to “Buy” - Defense World
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock - Yahoo Finance
Limoneira And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
State Street Corp Sells 33,324 Shares of Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Barclays PLC Purchases 29,271 Shares of Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Phibro Animal Health Co. (NASDAQ:PAHC) Shares Sold by State Street Corp - MarketBeat
Wellington Management Group LLP Trims Holdings in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Morgan Stanley Issues Positive Forecast for Phibro Animal Health (NASDAQ:PAHC) Stock Price - MarketBeat
Phibro Animal Health Co. (NASDAQ:PAHC) Shares Bought by Fmr LLC - Defense World
BNP Paribas Financial Markets Grows Stock Holdings in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Zacks Research Analysts Boost Earnings Estimates for PAHC - Defense World
Zacks Research Brokers Increase Earnings Estimates for PAHC - MarketBeat
Equities Analysts Set Expectations for PAHC FY2025 Earnings - MarketBeat
Global Veterinary Vaccines Market is Predicted to Cross USD 16 Billion by 2030 | DelveInsight - The Malaysian Reserve
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term - Yahoo Finance
Phibro Animal Health (NASDAQ:PAHC) Stock Rating Lowered by StockNews.com - MarketBeat
Villanova Investment Management Co LLC Sells 31,210 Shares of Phibro Animal Health Co. (NASDAQ:PAHC) - MarketBeat
Phibro (PAHC) Down 2.5% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Zacks Industry Outlook Highlights ResMed, Haemonetics, Phibro and Agios - Yahoo Finance
Reasons to Add Phibro Stock to Your Portfolio Right Now - Yahoo Finance
What is Zacks Research's Forecast for PAHC Q1 Earnings? - MarketBeat
Here is Why Growth Investors Should Buy Phibro (PAHC) Now - Yahoo Finance
Phibro Animal Health Co. (NASDAQ:PAHC) Stock Holdings Lifted by Algert Global LLC - MarketBeat
Phibro Animal Health (NASDAQ:PAHC) Stock Rating Upgraded by StockNews.com - MarketBeat
PAHC (Phibro Animal Health) 5-Year Dividend Growth Rate : 0.60% (As of Sep. 2024) - GuruFocus.com
PAHC (Phibro Animal Health) Free Cash Flow per Share : $1.00 (TTM As of Sep. 2024) - GuruFocus.com
PAHC (Phibro Animal Health) Effective Interest Rate on Debt % : 6.30% (As of Sep. 2024) - GuruFocus.com
Why Phibro Animal Health (PAHC) is a Top Momentum Stock for the Long-Term - Yahoo Finance
PAHC (Phibro Animal Health) EPS without NRI : $1.40 (TTM As of Sep. 2024) - GuruFocus.com
U.S. Animal Health Market Size, Share | Industry Report 2030 - Grand View Research
Zacks Research Has Pessimistic Outlook of PAHC Q3 Earnings - MarketBeat
PAHC (Phibro Animal Health) 50-Day SMA : $23.16 (As of Nov. 24, 2024) - GuruFocus.com
Atria Investments Inc Has $283,000 Position in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
PAHC (Phibro Animal Health) FCF Margin % : 1.17% (As of Sep. 2024) - GuruFocus.com
Zacks Research Has Pessimistic Outlook of PAHC Q2 Earnings - MarketBeat
Phibro Animal Health (NASDAQ:PAHC) Lowered to Buy Rating by StockNews.com - MarketBeat
Phibro Animal Health (NASDAQ:PAHC) Rating Lowered to Buy at StockNews.com - Defense World
Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12 - Yahoo Finance
Phibro Animal Health Corp Azioni (PAHC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.12%
0.89%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):